Bosutinib R&D manufacturer

Bosutinib is developed and produced by Pfizer Pharmaceuticals of the United States. Bosutinib is used to treat a type of blood cancer in adults called Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Bosutinib(Bosutinib) was approved for marketing by NikkeiFDA in 2012Year9Month4 NikkeiFDA.

Common side effects of bosutinib include headache, nausea, vomiting, diarrhea, stomach pain, fever, cough, abnormal liver function tests, swelling, rash, or low blood cell counts. It should not be used ifthe patientis allergic to bosutinib before taking the drug. Please tell the doctorif the patient has heart disease, liver disease, or kidney disease. Before starting this treatment, patients may need to have a negative pregnancy test. Bosutinib may harm your unborn baby. Use effective birth control while you are using bosutinib, and for at least2 weeks after the last dose. You should not breastfeed while you are taking this medicine and for at least 2 weeks after your last dose.

Bosutinib has a generic version in India, and it is a officially marketed version with government approval. The retail price in Indian pharmacies is about 500mg30 capsules1550 yuan, 100mg120 tablets1800yuan, 400mg30 tablets1300yuan. If patients purchase Indian generic drugs, they can contact regular domestic overseas medical consulting agencies, receive direct mail from pharmacies, issue invoices and sign contracts to provide guarantees. Drugs and all aspects are guaranteed. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.

xa0